Seeking Alpha

Clovis Oncology evaluating possible sale: Bloomberg

  • Shares of Clovis Oncology (CLVS +13.1%) spike midday on reports the company may be exploring a sale.
  • Credit Suisse is advising the company on its options, Bloomberg says, citing sources.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio: